The use of nanoparticles as nanotherapeutic platforms in drug delivery systems is currently being studied for various diseases or pathophysiological conditions, including chronic pain, and endometrial, prostate, and colorectal cancer.
Oncology faces the challenge of seeking early detection tools, developing more effective and less toxic molecules to fight cancer, and creating drug delivery systems that can reduce the side effects of treatments.
This is what Dr. Pedro Orihuela, a scholar at Universidad de Santiago de Chile, will tell us in detail this Thursday, September 30, at 4:00 PM, via Zoom.